A monoclonal antibody that blocks class II histocompatibility-related immune interactions |
| |
Authors: | Robert F. Todd Stefan C. Meuer Paul L. Romain Stuart F. Schlossman |
| |
Affiliation: | Division of Tumor Immunology, Data-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA |
| |
Abstract: | Previous studies using conventional hetero- or isoantisera have indicated the involvement of class II (Ia) molecules in presentation of soluble by monocytes to inducer T lymphocytes, stimulation of inducer T cells in MLR, and recognition of Ia-bearing targets cells by cytotoxic T lymphocytes (CTL). The experience in using monoclonal anti-Ia reagents capable of blocking these phenomena in the human system is limited. Recently, however, we have characterized a lytic IgG2a monoclonal antibody, 9–49, that binds to functionally significant class II molecules. This antibody blocks (in the absence of complement): (1) specific binding of peripheral blood lymphocytes (PBL) to antigen-pulsed monocyte monolayers, (2) proliferation of PBL in response to soluble antigen (tetanus toxoid or mumps) or cell surface class II antigen stimulation in allogeneic or autologus MLR, (3) proliferation of cloned T4+ (inducer) lymphocyte cell lines to class II antigens, (4) generation of cytotoxic lymphocytes during allogenic MLR, and (5) recognition (and killing) of class II-bearing target cells by T4+ CTL clones. Proliferation and CTL activity of a T8+ clone is unaffected by the 9–49 antibody. These results indicate the usefulness of this monoclonal reagent in studies evaluating the functional role of Ia molecules in immune recognition phenomena. |
| |
Keywords: | Address requests for reprints to Robert F. Todd III M.D. Ph.D. Division of Tumor Immunology Dana-Farber Cancer Institute 44 Binney Street Boston MA 02115. |
本文献已被 ScienceDirect 等数据库收录! |
|